BridgeBio Pharma, Inc. (BBIO) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$106.03M*; Operating income -$107.08M; Depreciation and amortization $1.05M*.
- 2026-03-31: Basis Reported; EBITDA -$104.77M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$138.13M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$143.80M*; Operating income -$145.20M; Depreciation and amortization $1.40M*.
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$106.03M* | -$107.08M | $1.05M* | $243.68M | -43.51%* | $443.00K* | -$71.10M* | (m) | $149.45M | $186.26M | $0.00 |
|---|
| 2026-03-31 | Reported | -$104.77M | (m) | (m) | (m) | (m) | $69.00K | -$197.28M | (m) | $126.64M | $163.90M | (m) |
|---|
| 2025-12-31 | Reported | -$138.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$143.80M* | -$145.20M | $1.40M* | $120.70M | -119.14%* | $470.00K* | -$109.57M* | (m) | $112.87M | $137.62M | -$1.54M |
|---|
| 2025-06-30 | Reported | -$132.96M* | -$134.28M | $1.32M* | $110.56M | -120.26%* | $594.00K* | -$80.68M* | (m) | $111.23M | $129.15M | $2.10M |
|---|
| 2025-03-31 | Reported | -$103.09M | (m) | (m) | (m) | (m) | $0.00 | -$199.24M | (m) | $111.43M | $106.36M | $0.00 |
|---|
| 2024-12-31 | Reported | -$224.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$190.21M* | -$191.75M | $1.54M* | $2.73M | -6962.37%* | $137.00K* | -$180.57M* | (m) | $120.44M | $68.82M | $0.00 |
|---|
| 2024-06-30 | Reported | -$173.97M* | -$175.54M | $1.57M* | $2.17M | -8024.22%* | $54.00K* | $74.70M* | (m) | $114.69M | $59.52M | $0.00 |
|---|
| 2024-03-31 | Reported | $1.94M | (m) | (m) | (m) | (m) | $695.00K | -$219.54M | (m) | $140.97M | $65.81M | $0.00 |
|---|
| 2023-12-31 | Reported | -$175.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$156.05M* | -$157.69M | $1.64M* | $4.09M | -3814.54%* | $431.00K* | -$145.23M* | (m) | $125.14M | $35.78M | $0.00 |
|---|
| 2023-06-30 | Reported | -$144.46M* | -$146.10M | $1.64M* | $1.64M | -8803.29%* | $428.00K* | -$113.35M* | (m) | $107.49M | $36.12M | $0.00 |
|---|
| 2023-03-31 | Reported | -$124.53M | (m) | (m) | (m) | (m) | $12.00K | -$144.32M | (m) | $92.86M | $31.11M | $0.00 |
|---|
| 2022-12-31 | Reported | -$127.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$127.47M* | -$129.12M | $1.65M* | $338.00K | -37713.31%* | $759.00K* | -$135.16M* | (m) | $92.51M | $31.19M | $0.00 |
|---|
| 2022-06-30 | Reported | -$78.59M* | -$80.18M | $1.58M* | $73.75M | -106.57%* | $2.40M* | -$30.45M* | (m) | $108.40M | $36.43M | $0.00 |
|---|
| 2022-03-31 | Reported | -$171.79M | (m) | (m) | (m) | (m) | $859.00K | -$160.63M | (m) | $107.65M | $43.71M | $0.00 |
|---|
| 2021-12-31 | Reported | -$164.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$149.23M* | -$149.50M | $265.00K* | $2.34M | -6366.64%* | $6.46M* | -$121.56M* | $1.45M | $104.31M | $46.08M | $0.00 |
|---|
| 2021-06-30 | Reported | -$90.53M* | -$94.02M | $3.49M* | $54.02M | -167.57%* | $2.29M* | -$91.71M* | $109.00K | $101.96M | $45.97M | $0.00 |
|---|
| 2021-03-31 | Reported | -$166.94M | (m) | (m) | (m) | (m) | $1.96M | -$150.76M | (m) | $122.56M | $45.41M | $0.00 |
|---|
| 2020-12-31 | Reported | -$127.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$120.95M* | -$119.94M | -$1.01M* | $8.13M | -1488.30%* | $549.00K* | -$131.68M* | $0.00 | $92.05M | $36.02M | $0.00 |
|---|
| 2020-06-30 | Reported | (m) | -$124.57M | (m) | (m) | (m) | $346.00K* | -$87.85M* | (m) | $86.60M | $37.97M | $0.00 |
|---|
| 2020-03-31 | Reported | (m) | -$102.49M | (m) | (m) | (m) | $4.48M | -$83.92M | (m) | $68.22M | (m) | $0.00 |
|---|
| 2019-09-30 | Reported | (m) | -$54.53M | (m) | $26.74M | (m) | $381.00K* | -$50.00M* | (m) | $55.28M | (m) | (m) |
|---|
| 2019-06-30 | Reported | (m) | -$69.32M | (m) | (m) | (m) | $83.00K* | -$68.25M* | (m) | $52.33M | (m) | (m) |
|---|
| 2019-03-31 | Reported | (m) | -$63.75M | (m) | (m) | (m) | $427.00K | -$59.14M | (m) | $44.85M | (m) | (m) |
|---|
| 2018-09-30 | Reported | (m) | -$41.46M | (m) | (m) | (m) | (m) | (m) | (m) | $31.15M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$517.98M | (m) | (m) | (m) | (m) | $1.10M | -$445.91M | (m) | $451.95M | $531.23M | $435.00K |
|---|
| 2024-12-31 | Reported | -$586.9M | (m) | (m) | (m) | (m) | $933.00K | -$520.73M | (m) | $506.46M | $288.93M | $1.15M |
|---|
| 2023-12-31 | Reported | -$600.88M | (m) | (m) | (m) | (m) | $1.31M | -$527.72M | (m) | $455.71M | $150.59M | $0.00 |
|---|
| 2022-12-31 | Reported | -$505.43M | (m) | (m) | (m) | (m) | $4.82M | -$419.49M | (m) | $399.46M | $143.19M | $0.00 |
|---|
| 2021-12-31 | Reported | -$570.79M | (m) | (m) | (m) | (m) | $13.25M | -$497.93M | $2.73M | $451.02M | $192.21M | (m) |
|---|
| 2020-12-31 | Reported | -$473.03M | (m) | (m) | (m) | (m) | $7.52M | -$399.71M | (m) | $337.05M | $145.68M | (m) |
|---|
| 2019-12-31 | Reported | -$265.38M | (m) | (m) | (m) | (m) | $2.64M | -$253.59M | (m) | $209.95M | $94.35M | (m) |
|---|
| 2018-12-31 | Reported | (m) | -$183.66M | (m) | (m) | (m) | $2.18M | -$136.64M | (m) | $140.07M | (m) | (m) |
|---|
| 2017-12-31 | Reported | (m) | -$43.86M | (m) | (m) | (m) | $464.00K | -$40.49M | (m) | $30.56M | (m) | (m) |
|---|